Methyl 3-(2-methoxyphenyl)oxirane-2-carboxylate
|
- $134.31 - $684
- Product name: Methyl 3-(2-methoxyphenyl)oxirane-2-carboxylate
- CAS: 33567-53-2
- MF: C11H12O4
- MW: 208.21
- EINECS:
- MDL Number:MFCD18089228
- Synonyms:Methyl 3-(2-methoxyphenyl)oxirane-2-carboxylate;2-Oxiranecarboxylic acid, 3-(2-methoxyphenyl)-, methyl ester
4 prices
Selected condition：
Brand
- AK Scientific
- Atlantic Research Chemicals
- Crysdot
- Matrix Scientific
Package
- 1g
- 250mgs:
- ManufacturerAK Scientific
- Product number0595AE
- Product descriptionMethyl3-(2-methoxyphenyl)oxirane-2-carboxylate
- Packaging1g
- Price$684
- Updated2021-12-16
- Buy
- ManufacturerAtlantic Research Chemicals
- Product numberES001133
- Product descriptionMethyl3-(2-Methoxyphenyl)oxirane-2-carboxylate 95%
- Packaging250mgs:
- Price$134.31
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12082195
- Product descriptionMethyl3-(2-methoxyphenyl)oxirane-2-carboxylate 95+%
- Packaging1g
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number083267
- Product descriptionMethyl 3-(2-methoxyphenyl)oxirane-2-carboxylate 97%
- Packaging1g
- Price$470
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0595AE | Methyl3-(2-methoxyphenyl)oxirane-2-carboxylate | 1g | $684 | 2021-12-16 | Buy |
| Atlantic Research Chemicals | ES001133 | Methyl3-(2-Methoxyphenyl)oxirane-2-carboxylate 95% | 250mgs: | $134.31 | 2021-12-16 | Buy |
| Crysdot | CD12082195 | Methyl3-(2-methoxyphenyl)oxirane-2-carboxylate 95+% | 1g | $326 | 2021-12-16 | Buy |
| Matrix Scientific | 083267 | Methyl 3-(2-methoxyphenyl)oxirane-2-carboxylate 97% | 1g | $470 | 2021-12-16 | Buy |
Properties
Boiling point :284.3±40.0 °C(Predicted)
Density :1.224±0.06 g/cm3(Predicted)
Density :1.224±0.06 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|